Abstract:ID 96308 Poster Board 554 Ca 2+ , a divalent cation, affects almost all aspects of cell life and death, thus understanding the basic principles controlling its cytosolic fluctuation is vital to the development of drugs targeting specific Ca 2+ release mechanisms. Activation of PLCβ enzymes by GPCRs, the largest membrane protein family in the human genome and the targets of 30% of today's prescription medicines, is a common mechanism to trigger the cytosolic Ca 2+ release in human cells. Both G iβ and G αq , activated by G i -coupled and G q -coupled receptors, respectively, can trigger intracellular calcium mobilization. We found previously that the recently available G q inhibitor FR900358 (UBO) can inhibit both G iβ and G αq -mediated Ca 2+ increase [1]. Pfeil et al. (2020) confirmed our finding and further explored the underlying mechanisms [2]. They found that "the G αi -G β -PLCβ-Ca 2+ signaling module is entirely dependent on the presence of active G αq . If G αq is pharmacologically inhibited or genetically ablated, G αq can bind to PLCβ but does not elicit Ca 2+ signals." The finding related to G q/11 control of G iβ -mediated Ca 2+ signaling is an important discovery. However, the conclusion that G αq controls G iβ -mediated Ca 2+ increases was drawn mostly from the study of HEK293 cells. In the present study, we further explored whether this is the case in other types of cells. Indeed, both G q/11 knockout and G q/11 inhibitors completely blocked P2Y 1 -, A 1 AR- and A 2B AR-mediated calcium increase in HEK293 cells. However, in T24 bladder cancer cells, the G i inhibitor PTX and G s inactivator CTX, but not the G q inhibitors FR900358 and YM254890 or G q/11 siRNA, inhibited A 2B AR-mediated intracellular Ca 2+ mobilization. Simultaneous inactivation of both Gi and Gs completely blocked A 2B AR-triggered Ca 2+ increase. Both PKA inhibitor H89 and EPAC inhibitor ESI-09 partially diminished the Ca 2+ increase in T24 cells, but the combination of two inhibitors did not produce an effect. Neither β-arrestin1 not β-arrestin2 siRNA affected the Ca 2+ increase. PKC activator PMA only partially diminished A 2B AR-mediated, but completely blocked β 2 -adrenergic receptor-mediated Ca 2+ increase. The G q inhibitor YM254890 partially inhibited β 2 -adrenergic receptor-induced Ca 2+ increase, although without effect on A 2B AR-triggered Ca 2+ increase. Thus, we confirmed that G αq is indeed vital for G iβ -increased Ca 2+ in HEK293 cells, but G αq is not involved in G iβ -triggered Ca 2+ release in T24 bladder cancer cells upon the activation of the native A 2B AR. It seems that G αq/11 may or may not participate in G iβ -mediated Ca 2+ signaling depending on type of cells and receptors. Gao ZG, Jacobson KA. On the selectivity of the G αq inhibitor UBO-QIC: A comparison with the G αi inhibitor pertussis toxin. Biochem. Pharmacol. 2016;107:59–66. Pfeil EM et al. Heterotrimeric G protein subunit G αq Is a master switch for Gβ-mediated calcium mobilization by G i -coupled GPCRs. Mol. Cell. 2020;80:940–954.

Gα i is required for carvedilol-induced β 1 adrenergic receptor β-arrestin biased signaling

Gαi is Required for Carvedilol-Induced Β1 Adrenergic Receptor Β-Arrestin Biased Signaling.

Biased agonism of carvedilol in the beta1-adrenergic receptor is governed by conformational exclusion

Distinct Conformations of GPCR–β-arrestin Complexes Mediate Desensitization, Signaling, and Endocytosis

Arrestin-biased AT1R Agonism Induces Acute Catecholamine Secretion Through TRPC3 Coupling

Mechanoactivation of the Angiotensin II Type 1 Receptor Induces Β‐arrestin‐biased Signaling Through Gαi Coupling

Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias

Molecular basis of β-arrestin coupling to formoterol-bound β1-adrenoceptor

Tyrosine 308 is Necessary for Ligand-directed Gs Protein-biased Signaling of Β2-Adrenoceptor

A New Series of Gs‐ and Β‐arrestin‐biased Β2‐adrenoceptor Agonists

A2B adenosine receptor-mediated intracellular calcium mobilization: Involvement of Gi, Gq, Gs, {beta}-arrestins, and protein kinase C

β-Arrestin-1 directly interacts with Gαs and regulates its function

Abstract 315: Mechanical Stretch Activates Biased AT1R Signaling and a Distinct Β-Arrestin Conformation

Β-Arrestin–biased Allosteric Modulator Potentiates Carvedilol-Stimulated Β Adrenergic Receptor Cardioprotection

A novel <sub>2</sub>-AR agonist, Higenamine, induces -arrestin-biased signaling

A novel β2-AR agonist, Higenamine, induces β-arrestin-biased signaling.

Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility

Abstract MP133: Development of Β-Arrestin-biased Positive Allosteric Modulators for the Β 1 Adrenergic Receptor

Location-biased β-arrestin conformations direct GPCR signaling

Β-Arrestin2 Recruitment by Β-Adrenergic Receptor Agonists and Antagonists

Β-Adrenergic Signaling in the Heart: Dual Coupling of the Β2-Adrenergic Receptor to Gs and Gi Proteins